Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
Business Of Biotech
00:00
The Origin Story of Biosonic
Biosonic is the result of bone therapeutics acquisition of MedSatic, which you led this past summer. How did that acquisition come to pass? And when did the discussion sort of begin? Yeah, it's a good question. It was clear these two last two three last years that it was not really possible for venture capitals to get into our adventure and bring the money that we needed. But at a certain point, venture capitalists were not really there or enough to try to go further.
Transcript
Play full episode
